Health Library Logo

Health Library

Multiple Sclerosis

Uhlolojikelele

Thola ulwazi oluthe xaxa ku-neurologist u-Oliver Tobin, M.B., B.Ch., B.A.O., Ph.D.

Asazi ukuthi yini ebangela i-MS, kodwa kunezinye izinto ezingase zikhulise ingozi noma zibangele ukuqala kwayo. Ngakho-ke, nakuba i-MS ingase ibonakale kunoma iyiphi iminyaka, ikakhulukazi ivela kubantu abaneminyaka ephakathi kuka-20 no-40. Amazinga aphansi e-vitamin D nokuvezwa okuncane ekukhanyeni kwelanga, okuvumela umzimba wethu ukuba wenze i-vitamin D, kuhambisana nengozi eyenyuka yokuthuthukisa i-MS. Njengoba abantu abane-MS abanamanani aphansi e-vitamin D bathambekele ekubeni nesifo esinzima. Ngakho-ke abantu abanesisindo esiningi banamathuba amaningi okuthuthukisa i-MS kanye nabantu abane-MS futhi banesisindo esiningi bathambekele ekubeni nesifo esinzima kanye nokuqala okusheshayo kokuthuthuka. Abantu abane-MS nabafuma bathambekele ekubeni nezinye izikhathi zokubuyela, isifo esibi esithuthukayo, kanye nezimpawu ezingathandeki. Abafazi banamathuba amathathu okuba ne-MS enqamula-nqamula kunamadoda. Ingozi ye-MS kubantu abavamile cishe i-0.5%. Uma umzali noma umfowabo noma udadewabo enesifo se-MS, ingozi yakho cishe iphindwe kabili noma cishe i-1%. Ukutheleleka okuthile kubalulekile. Izinhlobo ezihlukahlukene zama-virus ziye zahlanganiswa ne-MS, kufaka phakathi i-Epstein-Barr virus, ebangela i-mono. Ama-latitude aseNyakatho naseningizimu anamazinga aphezulu, kuhlanganise neCanada, i-US enyakatho, i-New Zealand, iningizimu-mpumalanga ye-Australia, neYurophu. Abantu abamhlophe, ikakhulukazi abavela enyakatho yeYurophu, banengozi enkulu. Abantu abavela e-Asia, e-Afrika, nase-Native America banengozi encane. Ingozi encane eyenyuka iyabonakala uma isiguli sesivele sinomdlavuza we-autoimmune thyroid, i-anemia pernicious, i-psoriasis, i-type 1 diabetes, noma isifo sokuvuvukala sezisu.

Okwamanje ayikho i-test eyodwa yokwenza ukuxilongwa kwe-MS. Noma kunjalo, kunezimpawu ezine eziyinhloko ezisiza ekuqinisekiseni ukuxilongwa. Okokuqala, ingabe kunezinhlobo zezimpawu ze-multiple sclerosis? Futhi, lezo zilahleko lombono elinye iso, ukulahleka kwamandla engalo noma umlenze, noma ukuhlupheka komuzwa engalweni noma umlenze okuhlala isikhathi esingaphezu kwamahora angu-24. Okwesibili, ingabe unezinye izinto ezitholakala ekuhlolweni komzimba ezihambisana ne-MS? Okulandelayo, ingabe i-MRI yobuchopho bakho noma umgogodla ihambisana ne-MS? Manje lapha kubalulekile ukuqaphela ukuthi i-95% yabantu abangaphezu kweminyaka engu-40 banesifo esingavamile se-MRI yobuchopho, njengoba nje abaningi bethu sinama-wrinkles olukhuni. Ekugcineni, ingabe imiphumela yokuhlaziywa kwe-spinal fluid ihambisana ne-MS? Udokotela wakho angase akukhuthaze ukuhlolwa kwegazi ukuhlola ezinye izifo ezinazo izimpawu ezifanayo. Bangase futhi bakhuthaze i-OCT test noma i-optical coherence tomography. Lokhu kuyiskena elifushane lobukhulu bezingqimba ngemuva kwamehlo akho.

Ngakho-ke into engcono kakhulu ongayenza uma uphila ne-MS ukufumana iqembu lezokwelapha elithenjiwe lezinhlangano ezingakusiza ukulandelela nokuphatha impilo yakho. Ukuba neqembu lezinhlangano eziningi kubalulekile ekubhekaneni nezimpawu zomuntu siqu ozibhekana nazo. Uma une-MS attack noma ukubuyela, udokotela wakho angase akubhalele ama-corticosteroids ukunciphisa noma ukuthuthukisa izimpawu zakho. Futhi uma izimpawu zakho zokuhlasela zingaphenduli kuma-steroids, enye indlela yi-plasmapheresis noma ukushintshwa kwe-plasma, okuyindlela yokwelapha efana ne-dialysis. Cishe i-50% yabantu abangaphenduli kuma-steroids banokuzuza okukhulu ngesikhathi esifushane sokushintshwa kwe-plasma. Kunezinye izidakamizwa ezingaphezu kuka-20 ezivunyelwe okwamanje zokuvimbela ukuhlaselwa kwe-MS nokuvimbela izifo ezintsha ze-MRI.

Ku-multiple sclerosis, ukumbozwa okuvikelayo ezintweni zezinzwa kulimala futhi kungase kugcinwe kubhujiswe. Lokhu kuboshwe okuvikelayo kubizwa ngokuthi i-myelin. Kuye ngokuthi ukubhujiswa kwezinzwa kwenzeka kuphi, i-MS ingathinta umbono, umuzwa, ukuxhumana, ukuhamba, kanye nokulawula kwesisu noma izisu.

Multiple sclerosis yisifo esibangela ukuphazamiseka kokumbozwa okuvikelayo kwezinzwa. Multiple sclerosis ingabangela ukungathandeki, ubuthakathaka, ukuhlupheka ekuhambeni, ukuguquka kombono nezinye izimpawu. Kuyaziwa nangokuthi yi-MS.

Ku-MS, uhlelo lokuphephakazi lomzimba luhlasele i-sheath evikela ehlanganisa ucingo lwezinzwa, oluaziwa ngokuthi yi-myelin. Lokhu kuphazamisa ukuxhumana phakathi kobuchopho nezinye izingxenye zomzimba. Ekugcineni, isifo singabangela umonakalo ophakade wezingqimba zezinzwa.

Izimpawu ze-MS ziyahlukahluka kuye ngumuntu, indawo yomonakalo ohlelweni lwezinzwa nokuthi umonakalo wezingqimba zezinzwa ukhulu kangakanani. Abanye abantu bayalahlekelwa ikhono lokuhamba bodwa noma ukuhamba nhlobo. Abanye bangaba nezikhathi ezinde phakathi kokuhlasela ngaphandle kwezimpawu ezintsha, okuthiwa yi-remission. Indlela yesifo iyahlukahluka kuye ngohlobo lwe-MS.

Asikho isilondolozi se-multiple sclerosis. Noma kunjalo, kunezinye izindlela zokwelapha ezisiza ekusizeni ukubuyela kokuhlasela, ukuguqula indlela yesifo nokuphatha izimpawu.

Ezinye izimo zihlelwa njengezigaba, kodwa i-multiple sclerosis ihlelwa njengezinhlobo. Izinhlobo ze-MS ziyahlukahluka kuye ngokuthuthuka kwezimpawu kanye nokuqina kokubuyela. Izinhlobo ze-MS zihlanganisa:

Abantu abaningi abane-multiple sclerosis banohlobo oluqamula-nqamula. Bayahlangabezana nezikhathi zezimpawu ezintsha noma ukubuyela okuthuthukayo ezinsukwini noma emaviki futhi ngokuvamile kuyaqina ngokuphelele noma ngokuphelele. Lokhu kubuyela kulandelelwa yizikhathi ezolile zokuthuthukiswa kwesifo ezingase zihlale izinyanga noma iminyaka.

Okungenani i-20% kuya ku-40% yabantu abane-multiple sclerosis enqamula-nqamula ekugcineni bangathuthukisa ukuqhubeka okuzinzile kwezimpawu. Lokhu kuqhubeka kungase kube khona noma kungabi khona izikhathi zokuthuthukiswa futhi kwenzeka phakathi kweminyaka engu-10 kuya kwengu-40 yokuqala kwesifo. Lokhu kuwaziwa ngokuthi yi-secondary-progressive MS.

Ukuwohloka kwezimpawu ngokuvamile kuhlanganisa inkinga yokunyakaza nokuhamba. Izinga lokuqhubeka kwesifo liyahlukahluka kakhulu phakathi kwabantu abane-secondary-progressive MS.

Abanye abantu abane-multiple sclerosis bayahlangabezana nokuqala okuqhubekayo nokuqhubeka okuzinzile kwezimpawu ngaphandle kokubuyela. Lolu hlobo lwe-MS luwaziwa ngokuthi yi-primary-progressive MS.

I-clinically isolated syndrome ibhekisela esigabeni sokuqala sesimo esithinta i-myelin. Ngemva kokuhlolwa okwengeziwe, i-clinically isolated syndrome ingase ixilongwe njenge-MS noma isimo esihlukile.

I-radiologically isolated syndrome ibhekisela ezintweni ezitholakala kwi-MRI yobuchopho nomgogodla obukela njenge-MS kumuntu ongenazo izimpawu ezivamile ze-MS.

Izimpawu

Kwisifoqele esiningi, ukumbozwa okuvikelayo emithanjeni yezinzwa, okwaziwa ngokuthi i-myelin, ohlelweni lwezinzwa oluphakathi kulimale. Ngokuya ngendawo yomonakalo ohlelweni lwezinzwa oluphakathi, izimpawu zingase zenzeke, kufaka phakathi ukungabi namuzwa, ukukhahlela, ubuthakathaka, ukushintsha kokubona, izinkinga zesibindi nezamathumbu, izinkinga zokuqonda, noma ukushintsha kwesimo sengqondo, ngokwesibonelo.

Izimpawu zesifoqele esiningi zihlukahluka kuye ngumuntu. Izimpawu zingashintsha phakathi nohambo lwesifo kuye ngokuthi yimiphi imithanjeni yezinzwa eithintekayo.

Izimpawu ezivamile zihlanganisa:

  • Ukungabi namuzwa noma ukukhahlela.
  • Imizwa efana nokushaywa umbani okwenzeka ngezinye izinyathelo zentanyel, ikakhulukazi ukugoba intanyel phambili. Le mizwa ibizwa ngokuthi i-Lhermitte sign.
  • Ukungabi namandla okuhambisana.
  • Ukuphazamiseka ekuhambeni noma ukungakwazi ukuhamba nhlobo.
  • Ubuthakathaka.
  • Ukulahleka okuphelele noma okuphelele kokubona, ngokuvamile elinye iso ngesikhathi sinye. Ukulahleka kokubona ngokuvamile kwenzeka ngebuhlungu ngesikhathi sokuhamba kwamehlo.
  • Ukubona okubili.
  • Ukubona okuphazamisekile.
  • Ukukhungatheka nomuzwa oqondile wokuthi wena noma izindawo zakho zihamba, okwaziwa ngokuthi i-vertigo.
  • Ukuphazamiseka kokusebenza kobulili, kwamathumbu nangesibindi.
  • Ukukhathala.
  • Inkulumo ephazamisekile.
  • Izinkinga zokuqonda, ukucabanga nokuqonda ulwazi.
  • Ukushintsha kwesimo sengqondo.

Ukuqhubeka okuncane kokushisa komzimba kungalimaza izimpawu ze-MS isikhashana. Lezi azibhekwa njengokubuya kwezifo ezithile kodwa yi-pseudorelapses.

Isikhathi sokubona udokotela

Yenza i-aphoyintimenti nodokotela wakho noma omunye ochwepheshe wezempilo uma unezinkinga ezikukhathazayo.

Izimbangela

Imbangela ye-multiple sclerosis ayaziwa. Kubhekwa njengesiifo esibangelwa yisistimu yomzimba lapho isistimu yomzimba yokulwa nezifo ihlasela izicubu zayo. Ku-MS, isistimu yomzimba yokulwa nezifo ihlasela futhi ibhubhise izinto ezinhlanzi ezihlanganisa futhi zivikele imicu yezinzwa ebuchosheni nasemgogweni wasemuqolo. Le nto ehlanganisa amafutha ibizwa ngokuthi i-myelin.

I-myelin ingafaniswa nokumbozwa kokukhahlela kweentambo zombane. Uma i-myelin eyivikelo yonakele futhi umthambo wezinzwa ukhombile, imiyalezo ehamba kulelo thambo lezinzwa ingase ibe buthakathaka noma ivinjelwe.

Akucace ukuthi kungani i-MS ithuthukela kwabanye abantu hhayi kwabanye. Ukuhlanganiswa kwezinto zofuzo nezinto ezingaphandle kungase kukhulise ingozi ye-MS.

Izici eziyingozi

Izici ezandisa ingozi ye-multiple sclerosis zifaka phakathi:

  • Ubudala. I-MS ingahle ibe khona kunoma yiliphi iminyaka. Kodwa-ke, ukuqala kwenzeka kakhulu phakathi kweminyaka engama-20 nama-40.
  • Ubulili. Abafazi banethuba elingaphezulu kabili noma kathathu kunamadoda lokuba ne-MS ephindaphindayo-ehlala isikhathi esithile.
  • Umlando womndeni. Uma omunye wabazali bakho noma abazalwane bakho ube ne-MS, unesangozi elikhulu lokukhula lesifo.
  • Ukutheleleka okuthile. Izinhlobo ezahlukahlukene zezifo ezibangelwa yi-virus ziye zahlanganiswa ne-MS, kufaka phakathi i-Epstein-Barr. I-Epstein-Barr iwumkhuhlane obangela i-infectious mononucleosis.
  • Uhlanga. Abantu abanezinwele ezimhlophe, ikakhulukazi labo abavela eYurophu eNyakatho, banegozi elikhulu lokukhula kwe-MS. Abantu abavela e-Asia, e-Afrika noma e-Native American banegozi elincane. Ucwaningo lwakamuva luphakamisa ukuthi inani labadala abancane abamnyama nabangamaHispanic abane-multiple sclerosis lingaba likhulu kunalokho okwakucatshangelwa ngaphambili.
  • Isimo sezulu. I-MS ivame kakhulu ezindaweni ezinosimo sezulu esifudumele. Lokhu kufaka phakathi iCanada, i-United States enyakatho, i-New Zealand, i-southeastern Australia neYurophu.
  • I-Vitamin D. Ukuba namanqanaba aphansi e-vitamin D nokubhekana nelanga okuncane kuhlotshaniswa nengozi enkulu ye-MS. Inyanga ozalwe ngayo ingase futhi ithonye amathuba okukhula kwe-MS. Lokhu kuhlobene namanqanaba okubhekana nelanga uma umama ekhulelwe.
  • Ukukhuluphala. Abantu abakhuluphala noma ababekhuluphala ebuntwaneni banegozi elikhulu le-multiple sclerosis.
  • Ezinye izifo zokuzipheka ngokweqile. Unegozi elincane lokukhula kwe-MS uma unezinye izimo zokuzipheka ngokweqile. Lokhu kungafaka phakathi isifo se-thyroid, i-pernicious anemia, i-psoriasis, i-type 1 diabetes noma isifo sokuvuvukala esibilisini.
  • Ukubhema. Abantu ababhema banegozi elikhulu le-MS ephindaphindayo-ehlala isikhathi esithile kunabantu abangabhemi.
  • I-gut microbiome. Abantu abane-MS bangaba ne-gut microbiome ehlukile kunabantu abangenayo i-MS. Kuyadingeka ucwaningo olwengeziwe ukuqonda lobuxhulumene.
Izingqinamba

Izinkinga ze-multiple sclerosis zingafaka:

  • Ukuqina kwemisipha noma ukuqina.
  • Ukubamba, nakuba kunqabile kakhulu.
  • Ubuthakathaka obukhulu noma ukungakwazi ukuhamba, ngokuvamile ezingalweni noma emilenzeni.
  • Ukuphazamiseka kokusebenza kwesisu, amathumbu noma ubulili.
  • Ukuphazamiseka kokucinga nokukhumbula.
Ukuxilongwa

Ukuhlolwa okuphelele kwesistimu yezinzwa kanye nomlando wezokwelapha kuyadingeka ukuze kuhlonishwa i-MS.

Udokotela wezinzwa u-Oliver Tobin, uM.B., uB.Ch., uB.A.O., uPh.D., uyaphendula imibuzo ebuzwa kakhulu mayelana ne-sclerosis ephindaphindayo.

Ngakho-ke abantu abanesisindo esiningi banesilinganiso esiphezulu sokuthuthukisa i-MS kanye nabantu abane-MS abanesisindo esiningi bathambekele ekubeni nesifo esisebenzayo kakhulu kanye nokuqala okusheshayo kokuthuthuka. Ukudla okukhulu okuye kwabonakala kuvikelayo izinzwa yikudla kweMediterranean. Lokhu kudla kuphezulu ezinhlanzini, imifino, namantongomane, futhi kuphansi enyameni ebomvu.

Ngakho-ke lo mbuzo uvela kakhulu ngoba iziguli ezinale sclerosis ephindaphindayo ngezinye izikhathi zingaba nokuwohloka okwesikhashana kwezinkinga zazo ekushiseni noma uma zenza umsebenzi onzima. Into ebalulekile okumele iphawulwe ukuthi ukushisa akubangeli ukuhlaselwa yi-MS noma ukuphindaphinda kwe-MS. Futhi ngakho-ke akubi. Awukwenzi noma yiluphi uhlobo lokulimala oluhlala njalo uma lokhu kwenzeka. Ukuzivocavoca kunconywa kakhulu futhi kuvikelekile ebuchosheni nasemgogweni wamathambo.

Ososayensi abakaqondi ukuthi yiziphi izicubu ze-stem ezilusizo ku-MS, iyiphi indlela yokuzinika noma iyiphi inani lokubapha noma iyiphi isikhathi. Ngakho-ke okwamanje, ukwelashwa kwezicubu ze-stem akuconyiwe ngaphandle kokuba kuvivinywe okungokwelapha.

I-Neuromyelitis optica spectrum disorder noma i-NMOSD ne-MOG-associated disorder zingabangela izici ezifana ne-sclerosis ephindaphindayo. Lezi ziyavame kakhulu kubantu base-Asia noma base-Afrika-Amerika. Futhi udokotela wakho angakuncoma ukuhlolwa kwegazi ukuze kuvinjwe lezi zifo.

Kahle, into ebaluleke kakhulu ngokuba nokuxilongwa kwe-sclerosis ephindaphindayo ukuthi ungumuntu ophakathi kweqembu lakho lezokwelapha. Isikhungo esiphelele se-MS yindawo engcono kakhulu yokuphathwa kwe-sclerosis ephindaphindayo, futhi lokhu ngokuvamile kuhlanganisa odokotela abanolwazi olukhulu e-sclerosis ephindaphindayo, odokotela bezinzwa, kodwa futhi odokotela bezitho zokukhulula, abaphathi bezokwelapha bomzimba kanye nokulungiswa, izazi zengqondo, nabanye abaninzi abahlinzeki abanesithakazelo ekhethekile e-sclerosis ephindaphindayo. Ukuhlanganisa leli qembu elizungezile wena nezidingo zakho ezithile kuzokuthuthukisa imiphumela yakho ngokuhamba kwesikhathi.

Awekho amavivinyo athile e-MS. Ukuxilongwa kunikezwa ngokuhlanganiswa komlando wezokwelapha, ukuhlolwa komzimba, i-MRI kanye nemiphumela yokuphuma komgogodla. Ukuxilongwa kwe-sclerosis ephindaphindayo kuhlanganisa nokukhipha ezinye izimo ezingase ziveze izimpawu ezifanayo. Lokhu kuyaziwa njengokuxilongwa okuhlukile.

Isithombe se-MRI sobuchopho esibonisa izigxobo ezimhlophe ezihlotshaniswa ne-sclerosis ephindaphindayo.

Phakathi nokuphuma komgogodla, okwaziwa nangokuthi i-spinal tap, ngokuvamile ulela eceleni ngamadolo akho aphakanyisiwe esifubeni sakho. Khona-ke inhlanzi ifakwa emgodini womgogodla ngemuva kwakho ophansi ukuze iqoqe i-cerebrospinal fluid ukuze ihlolwe.

Amavivinyo asetshenziswa ukuze kuhlonishwa i-MS angafaka:

  • i-MRI, engabonisa izindawo ze-MS ebuchosheni nasemgogweni wamathambo. Lezi zindawo zibizwa ngokuthi izigxobo. I-dye contrast inganikezwa nge-IV ukuze ibonise izigxobo ezibonisa ukuthi isifo sisesigabeni esisebenzayo.
  • Ukuphuma komgogodla, okwaziwa nangokuthi i-spinal tap, lapho isampula encane ye-cerebrospinal fluid ikhishwa emgodini womgogodla ukuze ihlolwe elabhoratri. Lesi sampula singabonisa ukushintsha kuma-antibodies ahlotshaniswa ne-MS. Ukuphuma komgogodla kungasiza futhi ekukhipeni ukutheleleka nezinye izimo ezinezimpawu ezifanayo ne-MS. Ukuhlolwa kwe-antibody olufuna i-kappa free light chains kungase kube ngokushesha futhi kubize kancane kunokuvivinyo lwangaphambili lwe-spinal fluid ye-MS.
  • Optical coherence tomography, esebenzisa amaza okukhanya ukuze iveze izithombe zeso. Ku-MS, isimo esibizwa ngokuthi i-optic neuritis sibangela ukushintsha kwel retina. I-Optical coherence tomography ingasetshenziswa ukuze ilinganise ubukhulu bel retina. Ingabonisa futhi ukulimala kwe-retinal nerve fiber.
  • Amavivinyo e-evoked potential, aqopha izibonakaliso zamandla ezidalwa yisistimu yakho yezinzwa njengokuphendula ekukhuthazeni. Ukuhlolwa kwe-evoked potential kungasebenzisa ukukhuthazwa kokubona noma ukukhuthazwa kwamandla. Kule mihlola, ubuka iphethini ehambayo yokubona, njengoba ama-impulses amancane amandla afakwa ezicubu zakho ezinyaweni noma ezingalweni. Ama-electrodes alinganisa ukuthi ulwazi luhamba ngokushesha kangakanani emizileni yakho yezinzwa.
  • Ukuhlolwa kwegazi, okungasiza ekukhipeni ezinye izifo ezinezimpawu ezifanayo ne-MS. Ukuhlolwa kokuhlola ama-biomarkers athile ahlotshaniswa ne-MS kukhonjiswa. Le mihlola ingasiza ekuxilongweni lesifo.
  • Ukuhlolwa kwe-neuropsychological. Ukuhlolwa kwe-neuropsychological kuhlanganisa ukubuka ukuthi ubuchopho bakho busebenza kanjani. Ukuhlolwa kuhlola ukucabanga kwakho, ukukhumbula, ulimi kanye namakhono omphakathi. Kuhlola futhi ubuntu bakho kanye nendlela ozizwa ngayo. Izazi zengqondo ezinobuchwepheshe obukhulu, ezibizwa ngokuthi i-neuropsychologist, yenza lo mkhuba. Ukuhlolwa kwe-neuropsychological kubalulekile ku-MS ngoba abantu abaningi abanesifo banokuwohloka kokwazi. Lokhu kungafaka ukulahleka kwemikhumbulo nobunzima ngolimi kanye namakhono okucabanga athonya imisebenzi yansuku zonke. Ochwepheshe bakho bezempilo bangakunika ukuhlolwa okuyisisekelo ngokushesha nje uma uxilongwe. Khona-ke ungahlolwa kabusha ngokuhamba kwesikhathi.

Kubantu abaningi abane-relapsing-remitting MS, ukuxilongwa kulula. Ukuxilongwa kusekelwe ephenini lezimpawu ezihlotshaniswa ne-MS futhi kuqinisekiswe yimiphumela yokuhlolwa.

Ukuxilongwa kwe-MS kungaba nzima kubantu abanezinkinga ezingavamile noma isifo esithuthukayo. Ukuhlolwa okwengeziwe kungadingeka.

i-Brain MRI ivame ukusetshenziswa ukuze kusize ekuxilongweni kwe-sclerosis ephindaphindayo.

Ukwelashwa

Asikho ikhambi le-multiple sclerosis. Ukwelashwa kuvame ukugxila ekuqedeni ukubuyiselwa ekuhlaselweni, ukunciphisa ukuphindaphinda, ukuthambisa ukuqhubeka kwesifo nokulawula izimpawu ze-MS. Abanye abantu banezimpawu ezilula kangangokuthi akukho ukwelashwa okudingekayo.

Phakathi nokuhlaselwa kwe-MS, ungase welashwe ngokuthi:

  • Ukushintshaniswa kwe-plasma. Lolu lwelo lwela ukususa ingxenye elukhuni legazi lakho, elibizwa nge-plasma, nokuyihlukanisa emagagwini egazi lakho. Amaseli egazi bese ehlanganiswa nesisombululo seprotheni esibizwa nge-albumin bese ebuyiswa emzimbeni wakho. Ukushintshaniswa kwe-plasma kungase kusetshenziswe uma izimpawu zakho zintsha, zinzima futhi aziphendulanga kuma-steroids. Ukushintshaniswa kwe-plasma kwaziwa nangokuthi i-plasmapheresis.

Kunezindlela eziningi zokwelapha eziguqula isifo (DMTs) ze-relapsing-remitting MS. Ezinye zalezi DMTs zingaba usizo lwe-secondary-progressive MS. Eyodwa itholakala kwi-primary-progressive MS.

Iningi lempendulo yomzimba ehlobene ne-MS kwenzeka ezigabeni zokuqala zesifo. Ukwelashwa okunamandla ngalezi zidakamizwa ngokushesha ngangokunokwenzeka kunganciphisa izinga lokuphindaphinda nokuthambisa ukwakheka kwezifo ezintsha. Lezi zindlela zokwelapha zinganciphisa ingozi yezifo nokuwohloka kokukhubazeka.

Eziningi zezindlela zokwelapha eziguqula isifo ezisetshenziswa ekwelapheni i-MS zinezinkinga zempilo ezinzima. Ukukhetha ukwelashwa okulungile kuwe kuncike ezintweni eziningi. Izici zihlanganisa isikhathi sokuthi uke waba nesifo isikhathi esingakanani kanye nezimpawu zakho. Iqembu lakho lokunakekelwa kwezempilo libuye libheke ukuthi ukwelashwa kwangaphambili kwe-MS kuye kwasebenza yini nezinye izinkinga zakho zempilo. Iindleko nokuthi uhlela yini ukuba nezingane esikhathini esizayo nazo zingazici lapho unquma ukwelashwa.

Izinketho zokwelapha ze-relapsing-remitting MS zihlanganisa imithi yokugcoba, yokuluma nokufakwa.

Ukwelashwa okugobekayo kuhlanganisa:

  • Imithi ye-Interferon beta. Le mithi isebenza ngokuphazamisa izifo ezihlasela umzimba. Zinganciphisa ukuvuvukala nokukhulisa ukukhula kwama-nerve. Imithi ye-Interferon beta igcobwa phansi kwesikhumba noma emithanjeni. Inganciphisa inani lokuphindaphinda nokwenza kube lula.

Imiphumela emibi ye-interferons ingase ihlanganise izimpawu ezifana ne-flu kanye nemiphumela yendawo yokugcoba. Uzodinga ukuhlolwa kwegazi ukuze uqaphele ama-enzymes akho e-liver ngoba ukonakala kwe-liver kuyimbangela ebangela umphumela omubi wokusetshenziswa kwe-interferon. Abantu abathinte imithi ye-interferons bangase bathuthukise ama-antibodies anganciphisa ukuthi imithi isebenza kangcono kangakanani.

  • Glatiramer acetate (Copaxone, Glatopa). Le mithi ingase isize ukuvimba ukuhlaselwa kwesistimu yakho yokuthola amandla e-myelin. I-Glatiramer acetate igcobwa ngaphansi kwesikhumba. Imiphumela emibi ingase ihlanganise ukuvuvukala kwesikhumba endaweni yokugcoba nokuvuvukala.
  • Ofatumumab (Kesimpta, Arzerra). Le mithi ihlose amaseli abangela ukonakala kwesistimu yezinzwa. La maseli abizwa ngamaseli e-B. I-Ofatumumab inikezwa ngokugcoba phansi kwesikhumba. Inganciphisa ingozi yezifo ezintsha kanye nezimpawu ezintsha noma ezibi kakhulu. Imiphumela emibi engenzeka yi-infections, ukusabela kwendawo endaweni yokugcoba kanye nobuhlungu ekhanda.

Imithi ye-Interferon beta. Le mithi isebenza ngokuphazamisa izifo ezihlasela umzimba. Zinganciphisa ukuvuvukala nokukhulisa ukukhula kwama-nerve. Imithi ye-Interferon beta igcobwa phansi kwesikhumba noma emithanjeni. Inganciphisa inani lokuphindaphinda nokwenza kube lula.

Imiphumela emibi ye-interferons ingase ihlanganise izimpawu ezifana ne-flu kanye nemiphumela yendawo yokugcoba. Uzodinga ukuhlolwa kwegazi ukuze uqaphele ama-enzymes akho e-liver ngoba ukonakala kwe-liver kuyimbangela ebangela umphumela omubi wokusetshenziswa kwe-interferon. Abantu abathinte imithi ye-interferons bangase bathuthukise ama-antibodies anganciphisa ukuthi imithi isebenza kangcono kangakanani.

Ukwelashwa kokuluma kuhlanganisa:

  • Teriflunomide (Aubagio). Le mithi yokuluma yansuku zonke inganciphisa ukuphindaphinda. I-Teriflunomide ingabangela ukonakala kwe-liver, ukulahleka kweenwele nezinye izimpawu ezimbi. Le mithi ihlobene nokukhubazeka kokuzalwa uma ithathwa yibo bobabili abesilisa nabesifazane. Sebenzisa ukulawula ukubeletha uma uthatha le mithi futhi isikhathi esingafika eminyakeni emibili ngemva kwalokho. Izibhangqwana ezifuna ukukhulelwa zingakhuluma nochwepheshe wezokunakekelwa kwezempilo ngezindlela zokususa imithi emzimbeni ngokushesha. I-Teriflunomide idinga ukuhlolwa kwegazi njalo.
  • Dimethyl fumarate (Tecfidera). Le mithi yokuluma kabili ngosuku inganciphisa ukuphindaphinda. Imiphumela emibi ingase ihlanganise ukuqhuma, isifo sohudo, isicanucanu nokuncipha kwenani lamaseli egazi amhlophe. I-Dimethyl fumarate idinga ukuhlolwa kwegazi njalo.
  • Diroximel fumarate (Vumerity). Le khapulethi kabili ngosuku ifana ne-dimethyl fumarate kodwa ngokuvamile ibangela imiphumela emibi embalwa. Ivunyelwe ekwelapheni izinhlobo ze-MS eziphindaphindayo.
  • Monomethyl fumarate (Bafiertam) yamukelwe yi-U.S. Food and Drug Administration, ebizwa nangokuthi i-FDA, njengomuthi wokukhululwa okwephuzile onokusebenza okuhamba kancane futhi okuzinzile. Isikhathi sokukhululwa komuthi singasiza ekuthambiseni imiphumela emibi. Imiphumela emibi engenzeka yi-flushing, ukonakala kwe-liver, ubuhlungu esiswini kanye ne-infections.
  • Cladribine (Mavenclad). Le mithi ngokuvamile ilotshwe njengokwelashwa kwesibili kulabo abane-relapsing-remitting MS. Iphinde yamukelwe yi-secondary-progressive MS. Inikezwa ngezindlela ezimbili zokwelapha, ezisabalala phakathi nesikhathi esingamaviki amabili, phakathi neminyaka emibili. Imiphumela emibi ihlanganisa ukutheleleka kwe-upper respiratory, ubuhlungu ekhanda, iziphumu, ukutheleleka okukhulu nokuncipha kwenani lamaseli egazi amhlophe. Abantu abane-infections ezinde noma umdlavuza abafanele bathinte le mithi. Abantu abakhulelwe noma abancelisa nabo abafanele bathinte le mithi. Sebenzisa ukulawula ukubeletha uma uthatha i-cladribine futhi izinyanga eziyisithupha ezilandelayo. Ungadinga ukuhlolwa kwegazi njalo ngenkathi uthatha i-cladribine.

Ukwelashwa kokufakwa kuhlanganisa:

  • Natalizumab (Tysabri). Lena i-monoclonal antibody ebonakale inciphise amazinga okuphindaphinda nokuthambisa ingozi yokukhubazeka.

I-Natalizumab yenzelwe ukuvimba ukuhamba kwamaseli omzimba angalimaza ukusuka egazini lakho uya ebuchosheni nasemgogodleni wakho. Ingase icatshelwe njengokwelashwa kokuqala kwabanye abantu abane-relapsing-remitting MS noma njengokwelashwa kwesibili kwabanye.

Le mithi ikhuphula ingozi yokutheleleka okukhulu kwe-viral ebuchosheni elibizwa nge-progressive multifocal leukoencephalopathy (PML). Ingozi ikhuphuka kubantu abane-antibodies ezibangela i-PML JC virus. Abantu abangenayo ama-antibodies banezingozi ezincane kakhulu ze-PML.

  • Ublituximab (Briumvi). Lolu lwelo luyi-monoclonal antibody olusetshenziswa ekwelapheni izinhlobo ze-MS eziphindaphindayo. I-Ublituximab inikezwa nge-IV infusion ngenkathi iqapha. I-Ublituximab ingase isetshenziswe kubantu abangakwazi ukuthatha i-ocrelizumab. Imiphumela emibi ihlanganisa ukusabela kokufakwa, ukwanda kengozi yokutheleleka kanye nengozi enkulu yokulimaza i-fetal.
  • Alemtuzumab (Campath, Lemtrada). Lolu lwelo luyi-monoclonal antibody oluthambisa amazinga okuphindaphinda minyaka yonke futhi lubonisa izinzuzo ze-MRI.

Le mithi iyasiza ekuthambiseni ukuphindaphinda kwe-MS ngokuqondisa iprotheni ebusweni lamaseli omzimba nokunciphisa amaseli egazi amhlophe. Lo mphumela unganciphisa ukonakala kwama-nerve okubangelwa amaseli egazi amhlophe. Kodwa futhi ikhuphula ingozi yokutheleleka nezinye izimo zomzimba, kuhlanganise ingozi enkulu yezifo zokuzimela ze-thyroid kanye nesifo sezinso esingavamile esibangelwa ukungasebenzi kahle komzimba.

Ukwelashwa nge-alemtuzumab kuhlanganisa izinsuku ezinhlanu ezilandelayo zokufakwa okulandelelwa izinsuku ezintathu zokufakwa ngonyaka olandelayo. Ukusebenza kokufakwa kuyinto evamile nge-alemtuzumab.

I-Alemtuzumab itholakala kuphela ochwepheshe bezempilo ababhalisiwe. Abantu abaphathwa ngale mithi kufanele babhaliswe ohlelweni olukhulu lokuqapha ukuphepha kwemithi. I-Alemtuzumab ngokuvamile icelwa kulabo abane-MS enonya noma njengokwelashwa kwesibili uma ezinye izidakamizwa ze-MS azisebenzi.

Natalizumab (Tysabri). Lena i-monoclonal antibody ebonakale inciphise amazinga okuphindaphinda nokuthambisa ingozi yokukhubazeka.

I-Natalizumab yenzelwe ukuvimba ukuhamba kwamaseli omzimba angalimaza ukusuka egazini lakho uya ebuchosheni nasemgogodleni wakho. Ingase icatshelwe njengokwelashwa kokuqala kwabanye abantu abane-relapsing-remitting MS noma njengokwelashwa kwesibili kwabanye.

Le mithi ikhuphula ingozi yokutheleleka okukhulu kwe-viral ebuchosheni elibizwa nge-progressive multifocal leukoencephalopathy (PML). Ingozi ikhuphuka kubantu abane-antibodies ezibangela i-PML JC virus. Abantu abangenayo ama-antibodies banezingozi ezincane kakhulu ze-PML.

Ocrelizumab (Ocrevus). Le mithi yamukelwe yi-FDA ukwelapha kokubili i-relapsing-remitting ne-primary-progressive forms ze-MS. Lolu lwelo lunciphise izinga lokuphindaphinda kanye nengozi yokukhubazeka okuqhubekayo kwi-relapsing-remitting multiple sclerosis. Iphinde ihambise ukuqhubeka kwesifo se-primary-progressive multiple sclerosis.

Ukuhlolwa kwezokwelapha kubonise ukuthi kunciphise izinga lokuphindaphinda esifweni esiphindaphindayo futhi kuthambise ukuwohloka kokukhubazeka kokubili izinhlobo zesifo.

Alemtuzumab (Campath, Lemtrada). Lolu lwelo luyi-monoclonal antibody oluthambisa amazinga okuphindaphinda minyaka yonke futhi lubonisa izinzuzo ze-MRI.

Le mithi iyasiza ekuthambiseni ukuphindaphinda kwe-MS ngokuqondisa iprotheni ebusweni lamaseli omzimba nokunciphisa amaseli egazi amhlophe. Lo mphumela unganciphisa ukonakala kwama-nerve okubangelwa amaseli egazi amhlophe. Kodwa futhi ikhuphula ingozi yokutheleleka nezinye izimo zomzimba, kuhlanganise ingozi enkulu yezifo zokuzimela ze-thyroid kanye nesifo sezinso esingavamile esibangelwa ukungasebenzi kahle komzimba.

Ukwelashwa nge-alemtuzumab kuhlanganisa izinsuku ezinhlanu ezilandelayo zokufakwa okulandelelwa izinsuku ezintathu zokufakwa ngonyaka olandelayo. Ukusebenza kokufakwa kuyinto evamile nge-alemtuzumab.

I-Alemtuzumab itholakala kuphela ochwepheshe bezempilo ababhalisiwe. Abantu abaphathwa ngale mithi kufanele babhaliswe ohlelweni olukhulu lokuqapha ukuphepha kwemithi. I-Alemtuzumab ngokuvamile icelwa kulabo abane-MS enonya noma njengokwelashwa kwesibili uma ezinye izidakamizwa ze-MS azisebenzi.

I-physical therapy ingakha amandla emisipha futhi ithambelise ezinye zezimpawu ze-MS.

Lezi zindlela zokwelapha zingasiza ekuthambiseni ezinye zezimpawu ze-MS.

  • Ukwelashwa. Uchwepheshe we-physical noma we-occupational angakufundisa imizamo yokwelula nokomelela. Uchwepheshe angakubonisa futhi ukuthi ungasebenzisa kanjani amadivayisi ukwenza kube lula ukwenza imisebenzi yansuku zonke.

I-physical therapy kanye nosizo lokuhamba, uma kudingeka, ingasiza futhi ekulawuleni ubuthakathaka beenyawo nokwenza kube lula ukuhamba.

  • Imithi yokuthambisa imisipha. Ungase ube nobunzima bemisipha noma ukubamba, ikakhulukazi ezinyawo zakho. Imithi yokuthambisa imisipha efana ne-baclofen (Lioresal, Gablofen), i-tizanidine (Zanaflex) ne-cyclobenzaprine (Amrix, Fexmid) ingasiza. Ukwelashwa kwe-Onabotulinumtoxin A (Botox) kungenye indlela yokubamba imisipha.
  • Imithi yokwandisa isivinini sokuhamba. I-Dalfampridine (Ampyra) ingasiza ekuthuthukiseni kancane isivinini sokuhamba kwabanye abantu. Imiphumela emibi engenzeka yi-infections yomchamo, i-vertigo, ukungakwazi ukulala nobuhlungu ekhanda. Abantu abane-seizures noma ukungasebenzi kahle kwezinso abafanele bathinte le mithi.

Ukwelashwa. Uchwepheshe we-physical noma we-occupational angakufundisa imizamo yokwelula nokomelela. Uchwepheshe angakubonisa futhi ukuthi ungasebenzisa kanjani amadivayisi ukwenza kube lula ukwenza imisebenzi yansuku zonke.

I-physical therapy kanye nosizo lokuhamba, uma kudingeka, ingasiza futhi ekulawuleni ubuthakathaka beenyawo nokwenza kube lula ukuhamba.

I-Bruton's tyrosine kinase (BTK) inhibitor iyindlela yokwelapha ehlolwa kwi-relapsing-remitting multiple sclerosis ne-secondary-progressive multiple sclerosis. Isebenza ngokuguqula umsebenzi wamaseli e-B, angamaseli omzimba ohlelweni lwezinzwa oluphakathi.

Enye indlela yokwelapha ehlolwa kubantu abane-MS yi-stem cell transplantation. Lolu lwelo lubhubhisa uhlelo lomzimba lomuntu onale-MS bese ulushintsha ngamaseli e-stem aphilayo. Abacwaningi basacwaninga ukuthi lolu lwelo lunganciphisa yini ukuvuvukala kubantu abane-MS nokwenza kube lula "ukusetha kabusha" uhlelo lomzimba. Imiphumela emibi engenzeka yi-fever kanye ne-infections.

Uhlobo lwe-protein elibizwa nge-CD40L olutholakala kumaseli e-T lubonakale ludlala indima kwi-MS. Izifundo zakamuva zibonise ukuthi ukuvimba le protheni kungasiza ekulawuleni i-MS.

Imithi entsha ebizwa nge-phosphodiesterase inhibitor nayo ihlolwa. Le mithi isebenza ekuthambiseni ukuvuvukala ngokushintsha izimpendulo zesimiso somzimba ezilimazayo ezibonwa kwi-MS.

Abacwaningi nabo bafunda okwengeziwe ngendlela izindlela zokwelapha eziguqula isifo ezisebenza ngayo ekuthambiseni ukuphindaphinda nokunciphisa izifo ezihlobene ne-multiple sclerosis ebuchosheni. Kuyadingeka izifundo ezengeziwe ukuze kunqunywe ukuthi ukwelashwa kungalihambisa yini ukukhubazeka okubangelwa yisifo.

Ikheli: 506/507, 1st Main Rd, Murugeshpalya, K R Garden, Bengaluru, Karnataka 560075

Umshwana wokuzihlangula: I-August iyinkundla yolwazi lwezempilo futhi izimpendulo zayo azihlanganisi iseluleko sezokwelapha. Njalo thintana nochwepheshe bezokwelapha onelayisensi eduze nawe ngaphambi kokwenza noma yiluphi ushintsho.

Yenziwe eNdiya, yomhlaba